Hillman Q3 Adjusted EPS Beats; Macro Trims FY Sales Outlook
HLMN sits 16% above its 52-week low of $6.655.
Summary
Hillman matched last year's $0.22 adjusted EPS and grew Adjusted EBITDA to $90.2 million, but trimmed the top end of its full-year sales guidance to $1.660-$1.680 billion while holding EBITDA and free cash flow targets. Leverage rose to 3.4x after the Kanebridge acquisition.
Key Events · Earnings and Guidance · HLMN
-
Q3 Adjusted EPS Matches Consensus
Adjusted diluted EPS came in at $0.22, matching last year's $0.22 and above the $0.21 IBES estimate; Adjusted EBITDA rose to $90.2 million from $88.0 million on net sales of $457.5 million, up 7.7%.
-
Full-Year Sales Range Narrowed
FY 2026 net sales guidance was cut to $1.660-$1.680 billion from $1.670-$1.720 billion on the macro environment, while Adjusted EBITDA (~$285 million) and free cash flow ($105-$115 million) guidance was reiterated.
-
GAAP Profit Hit by Refinancing Costs
GAAP net income fell to $6.3 million ($0.03 per diluted share) from $23.2 million ($0.12), reflecting $13.5 million of refinancing costs tied to the new $735 million term loan B and $375 million ABL.
-
Leverage Rises to 3.4x After Kanebridge
Net debt of $932.6 million against $274.9 million trailing Adjusted EBITDA puts leverage at 3.4x versus 2.4x at December 27, 2025; management estimates ~3.1x assuming Kanebridge was owned for the full trailing period, against a long-term target under 2.5x.
Analysis · HLMN · Manufacturing
The core business held up: adjusted EPS of $0.22 matched last year and topped the $0.21 consensus, while Adjusted EBITDA rose to $90.2 million from $88.0 million. The top line is the catch. Management cut the high end of its full-year sales range to $1.660-$1.680 billion from $1.670-$1.720 billion, citing the macro environment, though Adjusted EBITDA (~$285 million) and free cash flow ($105-$115 million) guidance stayed intact. GAAP net income fell to $6.3 million from $23.2 million, largely on $13.5 million of refinancing costs booked this quarter. Leverage is the number to track: net debt to trailing Adjusted EBITDA jumped to 3.4x from 2.4x at year-end after the $315 million Kanebridge deal and related debt, versus a long-term target under 2.5x — management pegs it at roughly 3.1x including Kanebridge for the full trailing period.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HLMN was trading at $7.70 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $6.66 to $10.85. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.